MONZEVA EMPAGLIFLOZIN 25MG 30TAB

MONZEVA EMPAGLIFLOZIN 25MG 30TAB is an SGLT2 inhibitor used to lower blood sugar in adults with type 2 diabetes. Also helps reduce the risk of cardiovascular events and heart failure. How to use: One tablet daily as directed by a physician, with or without food. Effective in improving glycemic control and protecting the heart and kidneys when used as part of a comprehensive treatment plan. Provides support for better diabetes management. Store in a cool, dry place away from moisture and out of reach of children.